Piloting Pathways, a Hope-enhancing Intervention to Address Activity and Role Function in Metastatic Lung Cancer Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Metastatic Lung Cancer
- Sponsor
- Laurie McLouth
- Enrollment
- 53
- Locations
- 1
- Primary Endpoint
- Feasibility of Enrollment: Percentage of Eligible and Approached Patients Who Agree to Participate
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The purpose of this research is to determine the feasibility of a new supportive intervention, called Pathways, for patients with advanced stage and metastatic lung cancer.
Detailed Description
In this study, investigators will first test the Pathways procedures with 6 patients to identify any improvements that need to be made. Then, investigators will test the feasibility of the Pathways intervention with 20 patients who are undergoing cancer treatment for advanced stage or metastatic lung cancer. Pathways is designed to help patients set and pursue personal goals during lung cancer treatment. In this study, investigators want to see if they can recruit patients with lung cancer who are being treated at the University of Kentucky Markey Cancer Center to participate in the Pathways intervention.
Investigators
Laurie McLouth
Assistant Professor
University of Kentucky
Eligibility Criteria
Inclusion Criteria
- •new or recurrent stage IIIB, stage IIIC or stage IV non-small cell lung cancer (NSCLC) or extensive stage SCLC
- •18 years of age or older
- •ECOG PS 0-2/Karnofsky 60-100
- •3 to 12 weeks into active cancer treatment
Exclusion Criteria
- •unstable brain metastases
- •cognitive or psychiatric condition for which participating would be inappropriate
- •unable to speak and read English
Outcomes
Primary Outcomes
Feasibility of Enrollment: Percentage of Eligible and Approached Patients Who Agree to Participate
Time Frame: 9 months
Percentage of eligible and approached patients who agree to participate
Acceptability: Ratings
Time Frame: 9 months
Mean acceptability ratings on individual items of acceptability developed by study team (e.g., convenience of the intervention, helpfulness of the intervention, relevance of the intervention; scores of at least 7/10 on each item, possible range = 1-10, higher scores indicate higher acceptability).
Secondary Outcomes
- Hope - State Hope Scale (Snyder)(9 months)
- Lung Cancer Stigma - Lung Cancer Stigma Inventory (Hamann)(9 months)
- Purpose - PROMIS Meaning and Purpose 4a(9 months)
- PROMIS Satisfaction With Participation in Social Roles - Short Form 8a(9 months)
- Distress - PROMIS Depression Short Form 6a(9 months)